DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affe

Media formats available:

DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWire TV
DermwireTV: Counterfeit Botox Cases Widen; New HS Treatment Approved in Europe
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWire TV
DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWire TV
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
DermWire TV
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research

PracticalDermatology